Community Trust & Investment Co. trimmed its position in shares of HCA Healthcare Inc (NYSE:HCA) by 2.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 97,604 shares of the company’s stock after selling 2,347 shares during the period. Community Trust & Investment Co.’s holdings in HCA Healthcare were worth $11,754,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in HCA. Westside Investment Management Inc. acquired a new position in HCA Healthcare in the second quarter valued at approximately $34,000. Doyle Wealth Management acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $34,000. North Star Investment Management Corp. acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $42,000. NEXT Financial Group Inc acquired a new stake in shares of HCA Healthcare in the second quarter valued at approximately $43,000. Finally, CSat Investment Advisory L.P. boosted its holdings in shares of HCA Healthcare by 737.7% in the second quarter. CSat Investment Advisory L.P. now owns 578 shares of the company’s stock valued at $78,000 after acquiring an additional 509 shares during the period. Hedge funds and other institutional investors own 70.19% of the company’s stock.
Several equities research analysts have recently weighed in on HCA shares. Stephens set a $150.00 price objective on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, August 7th. ValuEngine raised HCA Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Bank of America raised HCA Healthcare from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $130.00 to $137.00 in a report on Friday, September 6th. UBS Group increased their price objective on HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a report on Monday, June 24th. Finally, Goldman Sachs Group raised HCA Healthcare from a “neutral” rating to a “buy” rating and increased their price objective for the company from $147.00 to $160.00 in a report on Wednesday, July 10th. Three investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. HCA Healthcare presently has an average rating of “Buy” and an average price target of $155.63.
Shares of NYSE HCA traded up $3.48 during mid-day trading on Friday, hitting $122.04. 11,513 shares of the company were exchanged, compared to its average volume of 1,581,667. The stock has a 50 day simple moving average of $121.98 and a 200-day simple moving average of $127.41. HCA Healthcare Inc has a 1-year low of $110.31 and a 1-year high of $147.42. The firm has a market cap of $39.77 billion, a price-to-earnings ratio of 12.39, a price-to-earnings-growth ratio of 1.00 and a beta of 0.87.
HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $2.21 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The company had revenue of $12.60 billion for the quarter, compared to analyst estimates of $12.61 billion. During the same period in the prior year, the business earned $2.29 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.3% compared to the same quarter last year. On average, equities analysts anticipate that HCA Healthcare Inc will post 10.4 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Tuesday, September 3rd were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.31%. The ex-dividend date was Friday, August 30th. HCA Healthcare’s dividend payout ratio is presently 16.38%.
In other HCA Healthcare news, SVP Kathleen M. Whalen sold 977 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $127.56, for a total value of $124,626.12. Following the completion of the transaction, the senior vice president now owns 11,484 shares in the company, valued at $1,464,899.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Patricia F. Elcan acquired 250 shares of the business’s stock in a transaction on Tuesday, August 6th. The stock was acquired at an average price of $124.10 per share, with a total value of $31,025.00. The disclosure for this purchase can be found here. 2.70% of the stock is owned by company insiders.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More: Relative Strength Index
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.